Annexon, Inc.

NasdaqGS:ANNX 주식 보고서

시가총액: US$547.9m

Annexon 미래 성장

Future 기준 확인 2/6

Annexon은 연간 수입과 매출이 각각 35.6%와 75.6% 증가할 것으로 예상되고 EPS는 연간 39.6%만큼 증가할 것으로 예상됩니다.

주요 정보

35.6%

수익 성장률

39.6%

EPS 성장률

Biotechs 수익 성장28.3%
매출 성장률75.6%
향후 자기자본 수익률n/a
애널리스트 커버리지

Good

마지막 업데이트20 Nov 2024

최근 미래 성장 업데이트

Recent updates

We're Hopeful That Annexon (NASDAQ:ANNX) Will Use Its Cash Wisely

Sep 27
We're Hopeful That Annexon (NASDAQ:ANNX) Will Use Its Cash Wisely

Speculative "Buy" Rating On Annexon: Evaluating The Potential Of ANX005 For GBS

Aug 17

Annexon: Complement Inhibition Of GBS Only The Beginning With Strong Tech In Place

Jun 04

Annexon: Unforced Error Sullies Prospects

Apr 03

Here's Why We're Watching Annexon's (NASDAQ:ANNX) Cash Burn Situation

Nov 10
Here's Why We're Watching Annexon's (NASDAQ:ANNX) Cash Burn Situation

Is Annexon (NASDAQ:ANNX) In A Good Position To Deliver On Growth Plans?

Jul 25
Is Annexon (NASDAQ:ANNX) In A Good Position To Deliver On Growth Plans?

Is Annexon (NASDAQ:ANNX) In A Good Position To Deliver On Growth Plans?

Apr 11
Is Annexon (NASDAQ:ANNX) In A Good Position To Deliver On Growth Plans?

Are Investors Undervaluing Annexon, Inc. (NASDAQ:ANNX) By 25%?

Feb 14
Are Investors Undervaluing Annexon, Inc. (NASDAQ:ANNX) By 25%?

We Think Annexon (NASDAQ:ANNX) Needs To Drive Business Growth Carefully

Dec 28
We Think Annexon (NASDAQ:ANNX) Needs To Drive Business Growth Carefully

Annexon started as a buy at Jefferies on market potential of candidates, data catalysts

Sep 16

Annexon: A First Take

Aug 21

Annexon Biosciences GAAP EPS of -$0.96 misses by $0.02

Aug 08

Annexon to raise $130M in stock and warrant offering

Jul 08

We're Keeping An Eye On Annexon's (NASDAQ:ANNX) Cash Burn Rate

Apr 16
We're Keeping An Eye On Annexon's (NASDAQ:ANNX) Cash Burn Rate

Companies Like Annexon (NASDAQ:ANNX) Are In A Position To Invest In Growth

Jan 01
Companies Like Annexon (NASDAQ:ANNX) Are In A Position To Invest In Growth

Companies Like Annexon (NASDAQ:ANNX) Are In A Position To Invest In Growth

Sep 08
Companies Like Annexon (NASDAQ:ANNX) Are In A Position To Invest In Growth

We Think Annexon (NASDAQ:ANNX) Can Afford To Drive Business Growth

May 22
We Think Annexon (NASDAQ:ANNX) Can Afford To Drive Business Growth

We Think Annexon (NASDAQ:ANNX) Can Afford To Drive Business Growth

Feb 06
We Think Annexon (NASDAQ:ANNX) Can Afford To Drive Business Growth

Dosing underway in Annexon's Phase 2/3 study of monoclonal antibody in Guillain-Barré Syndrome

Dec 21

Annexon Biosciences EPS misses by $0.43

Nov 16

수익 및 매출 성장 예측

NasdaqGS:ANNX - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/202654-149-119-1626
12/31/202511-159-136-1777
12/31/2024N/A-127-129-957
9/30/2024N/A-118-105-105N/A
6/30/2024N/A-115-102-102N/A
3/31/2024N/A-121-116-116N/A
12/31/2023N/A-134-121-121N/A
9/30/2023N/A-141-125-125N/A
6/30/2023N/A-143-128-127N/A
3/31/2023N/A-145-120-119N/A
12/31/2022N/A-142-123-116N/A
9/30/2022N/A-145-125-117N/A
6/30/2022N/A-145-124-116N/A
3/31/2022N/A-140-120-113N/A
12/31/2021N/A-130-108-106N/A
9/30/2021N/A-116-98-97N/A
6/30/2021N/A-103-81-81N/A
3/31/2021N/A-84-67-67N/A
12/31/2020N/A-70-54-53N/A
9/30/2020N/A-56-43-43N/A
6/30/2020N/A-45-36-36N/A
3/31/2020N/A-42-33-32N/A
12/31/2019N/A-38-29-28N/A
9/30/2019N/A-34-25-24N/A
6/30/2019N/A-28-21-21N/A
3/31/2019N/A-23-19-19N/A
12/31/2018N/A-18-17-17N/A

애널리스트 미래 성장 예측

수입 대 저축률: ANNX 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

수익 vs 시장: ANNX 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

고성장 수익: ANNX 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

수익 대 시장: ANNX 의 수익(연간 75.6% ) US 시장( 8.9% 보다 빠르게 성장할 것으로 예상됩니다. 8.9% 연간).

고성장 수익: ANNX 의 수익(연간 75.6% )은 연간 20% 보다 빠르게 증가할 것으로 예상됩니다.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: ANNX 의 자기자본수익률이 3년 내에 높을 것으로 예상되는지 판단하기에는 데이터가 부족합니다.


성장 기업 발견